中国医药
中國醫藥
중국의약
CHINA MEDICINE
2013年
4期
493-495
,共3页
雷丽%麻春杰%史丽芳%王滨%聂耀%牛仁秀
雷麗%痳春傑%史麗芳%王濱%聶耀%牛仁秀
뢰려%마춘걸%사려방%왕빈%섭요%우인수
萎缩性胃炎%胃和冲剂%三叶因子1
萎縮性胃炎%胃和遲劑%三葉因子1
위축성위염%위화충제%삼협인자1
Atrophic gastritis%Weihe granule%Trefoil factor 1
目的 观察胃和冲剂Ⅱ号对慢性萎缩性胃炎(CAG)大鼠胃黏膜三叶因子1(TFF1)和CD34表达的影响,探讨胃和冲剂Ⅱ号治疗CAG的作用机制.方法 将72只雄性Wistar大鼠随机分为正常对照组(12只)和造模组(60只).除正常对照组外,其余各组大鼠均使用综合造模法成功复制CAG动物模型(为确定造模成功,颈椎脱臼法处死9只大鼠).然后将53只CAG大鼠随机分为5组,分别为模型组(10只)、维酶素阳性对照组(11只)及胃和冲剂低、中、高剂量组(10只,11只,11只).治疗60d后,取各大鼠相同部位全层胃壁组织,采用免疫组化法分别检测胃黏膜组织的TFF1和CD34的表达水平.结果 TFF1在胃和冲剂高剂量组中的表达值(3.4±1.4),高于模型组(1.5±0.8)和维酶素组(1.7±0.9)(P<0.01);胃和冲剂高剂量组微血管密度值为(7.5±1.5),低于模型组(12.5±2.5)和维酶素阳性对照组(11.6±2.1),差异有统计学意义(P<0.01).结论 胃和冲剂Ⅱ号可能通过提高胃黏膜组织的TFF1表达、降低CD34的表达,加快胃黏膜细胞的修复和抑制过度增殖,从而对CAG起到治疗作用并可预防癌变.
目的 觀察胃和遲劑Ⅱ號對慢性萎縮性胃炎(CAG)大鼠胃黏膜三葉因子1(TFF1)和CD34錶達的影響,探討胃和遲劑Ⅱ號治療CAG的作用機製.方法 將72隻雄性Wistar大鼠隨機分為正常對照組(12隻)和造模組(60隻).除正常對照組外,其餘各組大鼠均使用綜閤造模法成功複製CAG動物模型(為確定造模成功,頸椎脫臼法處死9隻大鼠).然後將53隻CAG大鼠隨機分為5組,分彆為模型組(10隻)、維酶素暘性對照組(11隻)及胃和遲劑低、中、高劑量組(10隻,11隻,11隻).治療60d後,取各大鼠相同部位全層胃壁組織,採用免疫組化法分彆檢測胃黏膜組織的TFF1和CD34的錶達水平.結果 TFF1在胃和遲劑高劑量組中的錶達值(3.4±1.4),高于模型組(1.5±0.8)和維酶素組(1.7±0.9)(P<0.01);胃和遲劑高劑量組微血管密度值為(7.5±1.5),低于模型組(12.5±2.5)和維酶素暘性對照組(11.6±2.1),差異有統計學意義(P<0.01).結論 胃和遲劑Ⅱ號可能通過提高胃黏膜組織的TFF1錶達、降低CD34的錶達,加快胃黏膜細胞的脩複和抑製過度增殖,從而對CAG起到治療作用併可預防癌變.
목적 관찰위화충제Ⅱ호대만성위축성위염(CAG)대서위점막삼협인자1(TFF1)화CD34표체적영향,탐토위화충제Ⅱ호치료CAG적작용궤제.방법 장72지웅성Wistar대서수궤분위정상대조조(12지)화조모조(60지).제정상대조조외,기여각조대서균사용종합조모법성공복제CAG동물모형(위학정조모성공,경추탈구법처사9지대서).연후장53지CAG대서수궤분위5조,분별위모형조(10지)、유매소양성대조조(11지)급위화충제저、중、고제량조(10지,11지,11지).치료60d후,취각대서상동부위전층위벽조직,채용면역조화법분별검측위점막조직적TFF1화CD34적표체수평.결과 TFF1재위화충제고제량조중적표체치(3.4±1.4),고우모형조(1.5±0.8)화유매소조(1.7±0.9)(P<0.01);위화충제고제량조미혈관밀도치위(7.5±1.5),저우모형조(12.5±2.5)화유매소양성대조조(11.6±2.1),차이유통계학의의(P<0.01).결론 위화충제Ⅱ호가능통과제고위점막조직적TFF1표체、강저CD34적표체,가쾌위점막세포적수복화억제과도증식,종이대CAG기도치료작용병가예방암변.
Objective To explore the treatment effect of Weihe granule Ⅱ on chronic atrophic gastritis (CAG) by analyzing the expression level of trefoil factor 1 (TFF1) and CD34 in gastric mucosal of model rats of chronic atrophic gastritis(CAG).Methods Seventy-two male Wistar rats were randomly divided into two groups,control group (n =12) and model group (n =60).The rat model of CAG in model group was made by using the comprehensive modeling method.Then,all rats in model group were assigned into five sub-groups,namely model sub-group,vitacoenzyme control sub-group,low-dose,mediate-dose and high-dose Weihe granule Ⅱ sub-groups.Then all rats in each group were subject to the corresponding treatments for 60 days.The expression level of TFF1 and CD34 in the same gastric tissue of each rat were examined and compared with each groups.Results The expession of TFF1 in the high-dose weihe granule Ⅱ sub-group [(3.4 ± 1.4)] was higher than that in model subgroup [(1.5 ± 0.8)] and control sub-group [(1.7 ± 0.9)] (P < 0.01) ; and the microvascular density value,which were marked by CD34,was 7.5 ± 1.5 in the high-dose Weihe granule Ⅱ sub-group which was lower than those in model sub-group and vitacoenzyme control sub-group (P < 0.01).Conclusions Weihe granule Ⅱ can increase the expression level of TFF1 and decrease the expression level of CD34 in gastric mucosal,it can repair the gastric mucosal cells and inhibit the excessive proliferation,cure CAG and prevent cancer.